Diagnostic performances of D-dimer, prothrombin time, and red blood cell distribution width for coronary artery lesion in children with acute stage Kawasaki disease

Aim To evaluate the performances of D-dimer, prothrombin time (PT), and red blood cell distribution width (RDW) for the diagnosis of coronary artery lesion (CAL) in acute stage Kawasaki disease (KD). Methods Between January 2018 and January 2021, a total of 102 children with acute stage KD were included in this retrospective study. Among them, 36 KD children with CAL were divided into the CAL group, and 66 KD children without CAL were divided into the NCAL group. Independent predictors of CAL in acute stage KD were identified by using univariate and multivariate logistic regression analysis. Spearman correlations were used to evaluate the association between CAL in acute stage KD and different indicators. The diagnostic performance of different indicators for CAL in acute stage KD was analyzed by the receiver operating characteristic (ROC) curve. Results Compared with the NCAL group, children in the CAL group had significantly higher white blood cell count, lymphocyte count, platelet count, D-dimer, and RDW levels, but lower PT levels (all p < 0.05). Logistic regression analysis revealed that D-dimer (OR = 1.0, 95% CI: 1.004–1.012, p < 0.001), PT (OR = 0.4, 95% CI: 0.2–0.8, p = 0.01), and RDW (OR = 7.0, 95% CI: 2.6–19.2, p < 0.001) were independent predictors of CAL in children with acute stage KD. CAL showed a positive correlation with D-dimer (r = 0.4, p < 0.001) and RDW (r = 0.5, p < 0.001), and had a negative association with PT (r = −0.2, p < 0.05). The ROC curve analysis showed that the combination of the three indicators had the highest diagnostic performance for CAL in acute stage KD with an area under the curve (AUC) of 0.922 (sensitivity, 86.1%; specificity, 89.4%), compared with D-dimer (AUC = 0.736), PT (AUC = 0.640), and RDW (AUC = 0.819) alone. Conclusion A combination of D-dimer, PT, and RDW may help predict CAL in children with acute stage KD.

[1]  Wenhui Jiang,et al.  Red cell distribution in critically ill patients with chronic obstructive pulmonary disease. , 2022, Pulmonology.

[2]  K. Dou,et al.  Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study , 2021, Thrombosis Journal.

[3]  H. Cao,et al.  Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease , 2021, Pediatric Cardiology.

[4]  A. Biswas,et al.  The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19 , 2021, Journal of clinical medicine.

[5]  T. Kuijpers,et al.  CT Angiography or Cardiac MRI for Detection of Coronary Artery Aneurysms in Kawasaki Disease , 2021, Frontiers in Pediatrics.

[6]  W. Koenig,et al.  Inflammation and Cardiovascular Disease: The Future , 2021, European cardiology.

[7]  T. Tilak,et al.  Relation of D-dimer levels of COVID-19 patients with diabetes mellitus , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[8]  A. Gedalia,et al.  Kawasaki Disease: an Update , 2020, Current Rheumatology Reports.

[9]  [Recommendations for clinical management of Kawasaki disease with coronary artery lesions (2020 revision)]. , 2020, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[10]  Jie Tian,et al.  Insights Into Coronary Artery Lesions in Kawasaki Disease , 2020, Frontiers in Pediatrics.

[11]  D. Burgner,et al.  Kawasaki disease fact check: Myths, misconceptions and mysteries , 2020, Journal of paediatrics and child health.

[12]  Yonghong Guo,et al.  Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease , 2020, Scientific Reports.

[13]  Y. Hua,et al.  N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease , 2020, Scientific Reports.

[14]  S. Berkowitz,et al.  Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling , 2019, CPT: pharmacometrics & systems pharmacology.

[15]  P. Langford,et al.  Kawasaki Disease: The Role of Immune Complexes Revisited , 2019, Front. Immunol..

[16]  N. Lu,et al.  Serum D-dimer levels at admission for prediction of outcomes in acute pancreatitis , 2019, BMC Gastroenterology.

[17]  P. Fang,et al.  Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease. , 2018, European review for medical and pharmacological sciences.

[18]  Ping Huang,et al.  Is aspirin necessary in the acute phase of Kawasaki disease? , 2018, Journal of paediatrics and child health.

[19]  G. Kim,et al.  Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014 , 2017, Korean circulation journal.

[20]  M. Singhal,et al.  Role of imaging studies in Kawasaki disease , 2017, International journal of rheumatic diseases.

[21]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[22]  D. Agrawal,et al.  Kawasaki disease: etiopathogenesis and novel treatment strategies , 2017, Expert review of clinical immunology.

[23]  J. Lim,et al.  Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease , 2016, Korean journal of pediatrics.

[24]  G. Dangas,et al.  The current role and future prospects of D-dimer biomarker. , 2016, European heart journal. Cardiovascular pharmacotherapy.

[25]  D. Masuya,et al.  Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung Cancer , 2013, PloS one.

[26]  K. Patel,et al.  Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES. , 2013, International journal of cardiology.

[27]  T. Richards,et al.  Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. , 2013, International journal of cardiology.

[28]  T. Shimo,et al.  Prediction of the Risk of Coronary Arterial Lesions in Kawasaki Disease by Brain Natriuretic Peptide , 2011, Pediatric Cardiology.

[29]  L. Ferrucci,et al.  Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. , 2010, Clinical nutrition.

[30]  Kuender D Yang,et al.  Plasma Clusterin Levels in Predicting the Occurrence of Coronary Artery Lesions in Patients With Kawasaki Disease , 2010, Pediatric Cardiology.

[31]  Ş. Balta,et al.  Red cell distribution width: a novel inflammatory marker in clinical practice. , 2013, Cardiology journal.

[32]  M. Yılmaz,et al.  Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. , 2012, The American journal of cardiology.

[33]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[34]  L. Ferrucci,et al.  The Women’s Health and Aging Study , 2001 .

[35]  K. Johnson.  An Update. , 1984, Journal of food protection.

[36]  J. Cattell.  The Future of , 1961 .